首页> 外文期刊>American Journal of Transplantation >Transhilar Passage in Right Graft Live Donor Liver Transplantation: Intrahilar Anatomy and Its Impact on Operative Strategy
【24h】

Transhilar Passage in Right Graft Live Donor Liver Transplantation: Intrahilar Anatomy and Its Impact on Operative Strategy

机译:肝移植活体肝移植中的肝门通道:肝门内解剖及其对手术策略的影响

获取原文
获取原文并翻译 | 示例
           

摘要

The passage through the hilar plate during right graft live donor liver transplantation (LDLT) can have dangerous consequences for both donors and recipients. The purpose of our study was to delineate hilar transection and biliary reconstruction strategies in right graft LDLT, with special consideration of central and peripheral hilar anatomical variants. A total of 71 consecutive donors underwent preoperative three-dimensional (3D) CT reconstructions and virtual 3D hepatectomies. A three-modal hilar passage strategy was applied, and its impact on operative strategy analyzed. In 68.4% of cases, type I and II anatomical configurations allowed for an en block hilar transection with simple anastomotic reconstructions. In 23.6% of cases, donors had “difficult” type II and types III/IV hilar bile duct anatomy that required stepwise hilar transections and complex graft biliary reconstructions. Morbidity rates for our early (A) and recent (B) experience periods were 67% and 39%, respectively. (1) Our two-level classification and 3D imaging technique allowed for donor-individualized transhilar passage. (2) A stepwise transhilar passage was favored in types III and IV inside the right-sided hilar corridor. (3) Reconstruction techniques showed no ameliorating effect on early/late biliary morbidity rates.
机译:右移植活体肝移植(LDLT)过程中穿过肝门板可能对供体和受体都有危险的后果。我们的研究目的是在右侧移植物LDLT中划定肝门横切和胆道重建策略,并特别考虑中央和外周肺门的解剖变异。共有71位连续的供体接受了术前三维(3D)CT重建和虚拟3D肝切除术。应用三模式肝门穿刺策略,并分析其对手术策略的影响。在68.4%的病例中,I型和II型解剖结构允许通过简单的吻合重建术进行全肝门横断。在23.6%的病例中,供体具有“困难”的II型和III / IV型肝门胆管解剖结构,需要逐步进行肺门横切术和复杂的胆管重建术。我们早期(A)和近期(B)的发病率分别为67%和39%。 (1)我们的两级分类和3D成像技术允许供体个性化的肝门通过。 (2)在右侧肝门走廊内,III型和IV型建议采用阶梯式跨肝门通道。 (3)重建技术对早期/晚期胆道发病率没有改善作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号